Skip to main content
. 2022 Apr 26;11(5):844. doi: 10.3390/antiox11050844

Table 5.

Baseline urinary oxidative damage markers levels (geometric mean (SD)) according to baseline clinical characteristics.

GSH
(nmol/mL)
TBARS
(µmL)
8-Isoprostane
(pg/mL)
Pteridine
(µmL)
8-OH-dG
(pg/mL)
Gender Male 3.4 (1.6) 66 (3.3) 670 (1.2) 8.5 (2.7) 2754 (1.2)
Female 3.2 (2.0) 40 (2.6) * 603 (1.8) 8.5 (2.5) 3019 (1.4) *
Smoking Current 3.7 (1.5) 70 (3.4) 657 (1.2) 10.6 (2.1) 2842 (1.2)
Ex-smoker 3.24 (1.8) 38 (3.2) 650 (1.1) 6.9 (2.0) 2977 (1.2)
Never smoked 3.23 (1.9) 44 (2.8) 615 (1.7) 8.3 (2.7) 2975 (1.4)
Body mass index Normal weight 3.4 (1.8) 42 (3.0) 566 (3.0) 7.7 (3.0) 3013 (2.0)
Overweight 3.8 (1.8) 54 (3.0) 630 (2.0) 9.3 (2.0) 2791 (2.0)
Obese 3.2 (1.9) 45 (2.8) 649 (2.0) 8.5 (2.6) 3061 (1.5)
Diabetes + No 3.4 (1.9) 41.5 (1.1) 614 (1.7) 8.6 (2.7) 3019 (1.4)
Yes 2.9 (2.0) 74 (3.7) * 655 (1.1) 8.1 (2.0) 2708 (1.2) *
Hypertension + No 3.4 (1.9) 46 (3.0) 615 (2.0) 8.7 (2.7) 3083 (2)
Yes 2.8 (1.6) 47 (2.3) 650 (1) 7.6 (2) 2616 (1.3) *

+ previously diagnosed diabetes mellitus or hypertension. * p < 0.05.